RxDoctor Payments Data

Carl Rountree

Dermatology · Houston, TXNPI 1538185814

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Novartis at 39.5% of the total. Reporting peaked in 2020 at $1,127 and has fallen 64.7% since, to $398 in 2022. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.

$2,684in general payments, 2019–2025

Across 198 payments — averaging $13.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • UCB, Inc.$354
  • Mayne Pharma Commercial LLC$329
  • Lilly USA, LLC$245
  • Sanofi$202
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$126
  • plus $366 from 9 others

What the payments were for

  • Food & beverage$2,66999%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,684 in reported general payments places this provider in the 40th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Other dermatology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →